$5.85
0.061.04%
Last update: Jun 8, 2:15 PM
Strata Critical Medical Inc Analyst Ratings
SRTANASDAQ
M&A: Louisville Perfusion Services, Inc. ( was acquired by Strata Critical Medical (SRTA) on Tuesday, June 2, 2026 for $16.0M paid in cash
Strata Critical Medical Analyst Ratings and Price Targets | NASDAQ:SRTA | Benzinga
Strata Critical Medical Inc has a consensus price target of $7.81 based on the ratings of 4 analysts. The high is $8 issued by Craig-Hallum on March 25, 2026. The low is $7.25 issued by Lake Street on September 17, 2025. The 3 most-recent analyst ratings were released by Craig-Hallum, B. Riley Securities, and Lake Street on March 25, 2026, March 25, 2026, and December 2, 2025, respectively. With an average price target of $8 between Craig-Hallum, B. Riley Securities, and Lake Street, there's an implied 36.75% upside for Strata Critical Medical Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Craig-Hallum
B. Riley Securities
Lake Street
Lake Street
1calculated from analyst ratings
Analyst Ratings for Strata Critical Medical
Loading calendar...
FAQ
What is the target price for Strata Critical Medical (SRTA) stock?
The latest price target for Strata Critical Medical (NASDAQ:SRTA) was reported by Craig-Hallum on March 25, 2026. The analyst firm set a price target for $8.00 expecting SRTA to rise to within 12 months (a possible 36.75% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Strata Critical Medical (SRTA)?
The latest analyst rating for Strata Critical Medical (NASDAQ:SRTA) was provided by Craig-Hallum, and Strata Critical Medical initiated their buy rating.
When was the last upgrade for Strata Critical Medical (SRTA)?
There is no last upgrade for Strata Critical Medical
When was the last downgrade for Strata Critical Medical (SRTA)?
There is no last downgrade for Strata Critical Medical.
When is the next analyst rating going to be posted or updated for Strata Critical Medical (SRTA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Strata Critical Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Strata Critical Medical was filed on March 25, 2026 so you should expect the next rating to be made available sometime around March 25, 2027.
Is the Analyst Rating Strata Critical Medical (SRTA) correct?
While ratings are subjective and will change, the latest Strata Critical Medical (SRTA) rating was a initiated with a price target of $0.00 to $8.00. The current price Strata Critical Medical (SRTA) is trading at is $5.85, which is within the analyst’s predicted range.
